Plain-English translation of NCT06234410 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether a heart scan called computed tomography coronary angiography (CTCA) can help doctors identify which kidney transplant patients are at highest risk for future heart disease. The scan works by taking detailed pictures of the arteries in your heart. Researchers want to know if this scan is better than current methods at finding patients who need extra care before and after their transplant.
Heart disease is the biggest health risk for people with kidney failure and remains the leading cause of death even after transplantation. Current methods to check heart risk before transplant don't do a good job of identifying the highest-risk patients, so doctors need a better tool to help predict who might have problems and plan their care accordingly.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would receive a heart scan (CTCA) as part of your evaluation before your kidney transplant. The scan takes pictures of your heart's blood vessels and helps doctors understand your heart health risk. You would likely have this scan done once, and researchers would then follow your health outcomes to see if the scan was helpful in predicting your future risk.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United Kingdom